Table 2.
Final body weight, g | Serum calcium, mg/dL | Serum phosphorus, mg/dL | BUN, mg/dL | |
---|---|---|---|---|
NL | 554 ± 41 | 10.3 ± 0.5 | 4.9 ± 0.9 | 22 ± 5 |
CKD | 541 ± 36 | 9.0 ± 2.0 | 8.4 ± 1.9 | 49.2 ± 8.2 |
P value | NS | NS | < 0.001 | < 0.001 |
CKD – Calcium | 499 ± 47 ab | 11.9 ± 1.5 b | 7.0 ± 1.2 ab | 61.2 ± 10.5 ab |
CKD – Zoledronic acid | 531 ± 41 | 8.7 ± 1.9 | 7.6 ± 1.9 a | 56.2 ± 16.5 ab |
ANOVA P value | 0.04 | < 0.001 | < 0.001 | < 0.001 |
CKD-Scl AB | 505 ± 57 | 9.9 ± 2.0 a | 9.4 ± 3.9 | 64.4 ± 11.6 ab |
CKD-Scl AB + Ca | 515 ± 44 | 11.1 ± 2.7 a | 7.9 ± 2.1 | 58.4 ± 13.7 ab |
ANOVA P value | NS | 0.018 | 0.002 | < 0.001 |
Data as mean ± SD. Statistical comparisons were conducted as t-test (between NL and CKD), or ANOVA (between NL, CKD, CKD+Calcium, and CKD+Zoledronic Acid; and then between NL, CKD, CKD+Calcium, CKD+Scl AB, and CKD+Scl AB+Calcium). Statistically different (p < 0.05) values between CKD and NL are given in the t-test p values while differences in the ANOVA are noted relative to NL (a) and CKD (b).